Kinetics of quiescent cord blood stem/progenitor cells with high proliferative potential in stem-cell expansion culture

Cytotherapy

Volumn 5, Issue 6, 2003, Pages 500-508

  Goussetis, Evgenios ^a   Theodosaki, M ^a   Paterakis, G ^b   Stefanaki, K ^a   Tsecoura, C ^c   Papassarandis, C ^b   Graphakos, S ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^b Immunology Department and National Histocompatibility Center   (Greece)

^c Gen Distr Mater Hosp Helena Veni   (Greece)

Author keywords

Ex vivo expansion; HPP Q cells

Indexed keywords

FLT3 LIGAND; INTERLEUKIN 6; STEM CELL FACTOR; THROMBOPOIETIN; TRANSFORMING GROWTH FACTOR BETA ANTIBODY;

ARTICLE; CELL CULTURE; CELL CYCLE PARAMETERS; CELL KINETICS; CELL PROLIFERATION; CLONOGENIC ASSAY; CONTROLLED STUDY; EX VIVO STUDY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; MONONUCLEAR CELL; UMBILICAL CORD BLOOD;

EID: 0346339805     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240310003602     Document Type: Article

References (26)

1. Berardi AC, Wang A, Levine ID, et al. Functional isolation and characterization of human hematopoietic stem cells. Science 1995;267:104-7.
2. Traycoff CM, Kosac ST, Grigsby S et al. Evaluation of ex vivo expansion potential of cord blood and bone marrow hematopoietic progenitor cells using tracking and limiting dilution analysis. Blood 1995;85:2059-68.
3. Mayani H, Dragowska W, Landsdorp PM. Lineage commitment in human hemopoiesis involves asymmetric cell division of multipotent progenitors and does not appear to be influenced by cytokines. J Cell Physiol 1993;157:579-86.
4. Brummendorf TH, Dragowska W, Zijlmans JM et al. Asymmetric cell divisions sustain long-term hematopoiesis from single-sorted human fetal liver cells. J Exp Med 1998;188:1117-24.
5. Hatzfeld J, Li ML, Brown EL et al. Release of early human hematopoietic progenitors from quiescence by antisense transforming growth factor β1 or Rb oligunucleotides. J Exp Med 1991;174:925-9.
6. Cheng T, Sheh H, Rodrigues N et al. Transforming growth factor beta 1 mediates cell-cycle arrest of primitive hematopoietic cells independent of p21 (cip1/waf1) or p27 (kip 1). Blood 2001;98:3643-9.
7. Young JC, Varma A, DiGiusto D et al. Retention of quiescent hematopoietic cells with high proliferative potential during ex vivo stem cell culture. Blood 1996;87:545-56.
8. 1 phase of the cell cycle. Blood 1997;90:4384-93.
9. Ohishi K, Katayama N, Itoh R et al. Accelerated cell cycling of hematopoietic progenitors by the flt3 ligand that is modulated by transforming growth factor-beta. Blood 1996;87:1718-27.
10. + cells isolated from cord blood are highly enriched in long-term culture initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. Stem Cells 1998;16:387-96.
11. Fortunel N, Batard P, Hatzfeld A et al. High proliferative potential-quiescent cells: A working model to study primitive quiescent hematopoietic cells. J Cell Sci 1998;111:1867-75.
12. Taylor CR, Kledzik G. Immunologic techniques in surgical pathology - A spectrum of 'new' special stains. Hum Pathol 1981;12:590-6.
13. Fortunel N, Hatzfeld J, Kisselev S et al. Release from quiescence of primitive human hematopoietic stem/progenitor cells by blocking their cell-surface TGF-β type II receptor in a short-term in vitro assay. Stem Cells 2000;18:102-11.
14. + human cord blood cells. J Hematother Stem Cell Res 2000;9:827-40.
15. Denning-Kendall PA, Nicol A, Horsley H et al. Is in vitro expansion of human cord blood cells clinically relevant? Bone Marrow Transplant 1998;21:225-32.
16. Piacibello W, Sanavio E, Garetto L et al. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997;89:3500-7.
17. Zandstra PW, Conneally E, Piret JM et al. Ontogeny associated changes in the cytokine responses of primitive human hemopoietic cells. Br J Haematol 1998;101:770-8.
18. 0. Blood 2000;96:4185-93.
19. + cord blood cells after ex vivo expansion: Evidence for the amplification and self-renewal of repopulating stem cells. Blood 1999;93:3736-49.
20. Takatoku M, Sellers S, Agricola BA et al. Avoidance of stimulation improves engraftment of cultured and retrovirally transduced hematopoietic cells in primates. J Clin Invest 2001;108:447-55.
21. + human marrow cells that express low levels of kit protein are enriched for long-term marrow engrafting cells. Blood 1996;87:4136-42.
22. Fortunel NO, Hatzfeld A, Hatzfeld JA. Transforming growth factor-β: Pleiotropic role in the regulation of hematopoiesis. Blood 2000;96:2022-36.
23. Ducos K, Hatzfeld A, Heron A et al. The high proliferative potential-quiescent (HPP-Q) cell assay allows an optimized evaluation of gene transfer efficiency into primitive hematopoietic stem/progenitor cells. Gene Ther 2000;20:1790-4.
24. Fortunel N, Hatzfeld J, Aoustin L et al. Specific dose-response effects of TGF-beta 1 on developmentally distinct hematopoietic stem/progenitor cells from human umbilical cord blood. Hematol J 2000;1:126-35.
25. + hematopoietic stem cells. Exp Hematol 2000;28:1297-305.
26. + cells. Stem Cells 2001;19:505-13.